Global Dermatophytic Onychomycosis Treatment Market Size Covered By Global Analysis, Share, Segment, Type, Growth, Revenue Analysis Forecast 2028

Market Overview

The global dermatophytic onychomycosis treatment market size is predicted to reach USD 6.63 billion by 2028, exhibiting a CAGR of 7.4% during the forecast period. The rising prevalence of diabetes and incidences of chronic nail fungus infection will lead to heavy demand for dermatophytic onychomycosis treatment, which, in turn, will foster the growth of the market, it is mentioned in a report, titled "Dermatophytic Onychomycosis Treatment Market Size, Share & COVID-19 Impact Analysis, By Product Type (Tablets and Nail Paints), By Route of Administration (Oral and Topical), By Type (Prescribed and Over-the-Counter (OTC)), By Distribution Channel (Hospitals & Clinics, Retail Pharmacies, and Online Channels), and Regional Forecast, 2021-2028" the market size stood at USD 3.74 billion in 2020.

Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatophytic-onychomycosis-treatment-market-103310

The emergence of coronavirus has put the world into an uneasy stance. This health disaster has caused an utmost state of emergency throughout the world. However, a silver lining in this indisposed situation is the new regulations and nations' dedication to combat this severely dangerous disease. Numerous industries are fraught yet thriving to elevate from this catastrophe. Our team of researchers have analyzed the current COVID data and prepared reports with new tactical information to help sustain businesses during the global pandemic.

The report on the Dermatophytic Onychomycosis Treatment Market Reveals:

Future insights into the industry
An all-encompassing study of market size;
In-detail data on all the segments
Evidential information about competitors and prominent players
Market Driver:

Emergence of Topical Treatment Solutions to Augment Growth

The growing cases of liver damage in patients will lead to a high demand for the market in the near future. According to a survey conducted on dermatologists and podiatrists in the U.S. by Moberg Pharma AB in 2017, 7 out of 10 doctors avoid prescribing oral terbinafine owing to the risk of liver damage. The innovation and development of topical treatment solutions and oral anti-fungal drugs associated with liver damage will subsequently enable speedy expansion of the market. The rising need for improved topical solutions will impel dermatologists and podiatrists to present new theories for drug enhancement, which, in turn, will augur well for the market. Moreover, the increasing adoption of nail lacquers will consequently create new opportunities for the market during the forecast period. In addition, the increasing spending on R&D activities by major players will have a tremendous impact on the market in the foreseeable future.

Regional Analysis:

Increasing Prevalence of Onychomycosis to Aid Expansion in North America

The market size in North America stood at USD 1.65 billion in 2019. The growth in the region is attributed to rising cases of onychomycosis in the region. The growing R&D activities will further foster the growth of the market in the region. The increasing demand for Jublia will accelerate the growth of the market in the region. Europe is predicted to witness a high growth rate during the forecast period owing to the favorable health reimbursement policies in European countries such as Italy, Spain, and the U.K. The superior distribution of OTC drugs retail pharmacies such as Walgreens, and others will enable speedy expansion of the market in Europe. According to an article published in the Journal of the European Academy of Dermatology and Venereology, the prevalence of onychomycosis in Europe is 4.3%.

Asia Pacific is expected to rise tremendously in the forthcoming years due to the new product launches. The increasing prevalence of diabetes will spur opportunities for the market in the foreseeable future. The rising geriatric population will further improve the growth prospects of the market. In addition, the rising patient awareness and developing healthcare infrastructure in emerging economies will boost the market.

Key Development:

December 2019: Moberg Pharma, a Swedish pharmaceutical company announced that M0B-015, topical terbinafine under phase 3 clinical study has met the primary and secondary endpoint for the treatment of onychomycosis.

Ask for Customization @ https://www.fortunebusinessinsights.com/enquiry/customization/dermatophytic-onychomycosis-treatment-market-103310

The Report Lists the Main Companies in the Dermatophytic Onychomycosis Treatment Market:



Bausch Health Companies Inc.
Pfizer Inc.
Galderma
GlaxoSmithKline plc
Janssen Pharmaceuticals, Inc.
Cipla Inc.
Kaken pharmaceuticals Co., Ltd.
Other Prominent Players


Table Of Content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Major Diseases - For Key Countries
Pipeline Analysis
New Product Launches
Key Industry Developments - Mergers, Acquisitions and Partnerships
Key Trends
Global Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Product Type
Tablets
Nail Paints
Market Analysis, Insights and Forecast - By Route of Administration
Oral
Topical
Market Analysis, Insights and Forecast - By Type
Prescribed
Over-the-Counter (OTC)
Market Analysis, Insights and Forecast - By Distribution Channel
Hospitals & Clinics
Retail Pharmacies
Online Channels
Market Analysis, Insights and Forecast - By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
North America Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Product Type
Tablets
Nail Paints
Market Analysis, Insights and Forecast - By Route of Administration
Oral
Topical
Market Analysis, Insights and Forecast - By Type
Prescribed
Over-the-Counter (OTC)
Market Analysis, Insights and Forecast - By Distribution Channel
Hospitals & Clinics
Retail Pharmacies
Online Channels
Market Analysis, Insights and Forecast - By Country
S.
Canada
Europe Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Product Type
Tablets
Nail Paints
Market Analysis, Insights and Forecast - By Route of Administration
Oral
Topical
Market Analysis, Insights and Forecast - By Type
Prescribed
Over-the-Counter (OTC)
Market Analysis, Insights and Forecast - By Distribution Channel
Hospitals & Clinics
Retail Pharmacies
Online Channels
Market Analysis, Insights and Forecast - By Countries/ Sub-region
K.
Germany
France
Spain
Italy
Scandinavia
Russia
Rest of Europe
Asia Pacific Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Product Type
Tablets
Nail Paints
Market Analysis, Insights and Forecast - By Route of Administration
Oral
Topical
Market Analysis, Insights and Forecast - By Type
Prescribed
Over-the-Counter (OTC)
Market Analysis, Insights and Forecast - By Distribution Channel
Hospitals & Clinics
Retail Pharmacies
Online Channels
Market Analysis, Insights and Forecast - By Countries/ Sub-region
Japan
China
India
Australia
New Zealand
Southeast Asia
Rest of Asia Pacific
Rest of World Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Product Type
Tablets
Nail Paints
Market Analysis, Insights and Forecast - By Route of Administration
Oral
Topical
Market Analysis, Insights and Forecast - By Type
Prescribed
Over-the-Counter (OTC)
Market Analysis, Insights and Forecast - By Distribution Channel
Hospitals & Clinics
Retail Pharmacies
Online Channels
Competitive Analysis
Key Industry Developments
Global Market Share Analysis (2019)
Company Profiles (Overview, Product & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
GlaxoSmithKline plc
Pfizer Inc.
Galderma
Cipla Inc.
Janssen Pharmaceuticals, Inc.
Kaken Pharmaceuticals Co., Ltd.
Other Prominent Players
Strategic Recommendations
Continued. . .

Related Article @

https://marketresearchreportsfbi.wordpress.com/2021/11/08/autotransfusion-devices-market-by-technology-share-size-segmentation-revenue-analysis-forecast-2028/

https://www.theexpresswire.com/pressrelease/Global-Surgical-Sutures-Market-Is-Projected-To-Grow-From-USD-341-Billion-In-2021-To-USD-512-Billion-In-2028-At-A-CAGR-Of-60-During-Forecast-Period-2021-28_14667642

NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

This release was published on openPR.